A novel lectin-dependent activation pathway of complement
一种新的凝集素依赖性补体激活途径
基本信息
- 批准号:06044189
- 负责人:
- 金额:$ 1.54万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for international Scientific Research
- 财政年份:1994
- 资助国家:日本
- 起止时间:1994 至 无数据
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Serum mannose-binding protein(MBP)is a C-type lectin capable of activating the complement system (the lectin pathway). A serine protease designated MASP (MBP-associated serine protease) is involved in the activation by MBP,exerting C4-and C2-activating capacity when bound to MBP on its ligands.1.To clarify the mechanisms by which C1r/C1s is substitute for MASP in the activation of the lectin patheway, we measured the affinity of C1r/C1s or MASP to C1q and MBP in a Biacore apparatus. The results indicate that the affinities of the four possible mixtures are very similar. Since MBP-MASP and C1q-C1r/C1s complex were present in plasma, the other factors would influence the interaction of MBP and C1r/C1s.2.We inverstigated reconstitution of recombinant MBPs and MASP for exhibiting complement activation. Wild type rMBP was found to be able to be associated with MASP,resulting in complement activation, whereas rMBP_D in which glycine is substituted with asparatic acid in the fifth collagen re … More peat and responsible for the complement-dependent opsonic defect is unable to activate complement when incubated with MASP.These results indicate that lack of complement-activating capacity of rMBP_D might be due to inability of association with MASP.3.To evalute the role of MBP in rheumatoid arthritis, we characterized the MBP-binding substances in sera of these patients. An enzyme linked immunosorbent assay (ELISA) was performed to detect the MBP-binding substances in sera of patients with RA.Sera of patients with RA showed higher MBP binding compared with those of normal controls. To characterize the MBP-binding substances, we applied sera of two patients with RA to an immobilized MBP column. Both IgG and IgM-RF were found in the binding substances of patients with RA eluted from MBP-column, whereas IgG was found in that of normal control. The results of molecular sieve chromatography showed that the binding substances of patients with RA consisted of immune complexes containing IgG and IgM-RF.These binding substances were specifically bound to MBP,and then MBP-MASP complexes consumed C4. Therefore, MBP binds to immune complexes consisting of IgG and IgM-RF,and probably recognizes either mannose of IgM-RF or N-acethylglucosamine of agalacto IgG.The lectin pathway would be activated in sera of patients with RA. Less
血清甘露糖结合蛋白 (MBP) 是一种能够激活补体系统(凝集素途径)的 C 型凝集素,称为 MASP(MBP 相关丝氨酸蛋白酶)的丝氨酸蛋白酶参与 MBP 的激活,发挥 C4-和与配体上的MBP结合时的C2激活能力。1.阐明C1r/C1s替代MASP激活凝集素的机制我们在 Biacore 装置中测量了 C1r/C1s 或 MASP 对 C1q 和 MBP 的亲和力。结果表明,由于 MBP-MASP 和 C1q-C1r/C1s 复合物存在,因此四种可能的混合物的亲和力非常相似。血浆中,其他因素会影响MBP和C1r/C1s的相互作用。2.我们研究了重组MBP和MASP的重构野生型 rMBP 被发现能够与 MASP 相关,从而导致补体激活,而 rMBP_D(第五种胶原蛋白中的甘氨酸被天冬氨酸取代)则导致补体依赖性调理缺陷。与 MASP 一起孵育时无法激活补体。这些结果表明 rMBP_D 缺乏补体激活能力可能是由于无法与 MASP 结合所致。3.评估类风湿性关节炎中的MBP,我们对这些患者血清中的MBP结合物质进行了酶联免疫吸附测定(ELISA)来检测RA患者血清中的MBP结合物质。RA患者的血清表现出较高的MBP。为了表征 MBP 结合物质,我们将两名 RA 患者的血清应用到固定的 MBP 柱上,在结合中发现了 IgG 和 IgM-RF。分子筛层析结果显示,RA患者的结合物质开始为含有IgG和IgM-RF的免疫复合物。 MBP与MBP特异性结合,MBP-MASP复合物消耗C4,因此MBP与IgG和IgM-RF组成的免疫复合物结合,可能识别甘露糖或甘露糖。 IgM-RF或半乳糖IgG的N-乙酰氨基葡萄糖。RA患者血清中的凝集素途径会被激活。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
FUJITA Teizo其他文献
FUJITA Teizo的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('FUJITA Teizo', 18)}}的其他基金
The lectin complement pathway is involved in activation of the alternative pathway
凝集素补体途径参与旁路途径的激活
- 批准号:
21390086 - 财政年份:2009
- 资助金额:
$ 1.54万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Roles of host defense lectin.s in innate immunity
宿主防御凝集素在先天免疫中的作用
- 批准号:
13143204 - 财政年份:2001
- 资助金额:
$ 1.54万 - 项目类别:
Grant-in-Aid for Scientific Research on Priority Areas
Molecular basis of complement activation by ficolins throu the lectin pathsay
纤维胶蛋白通过凝集素途径激活补体的分子基础
- 批准号:
12470079 - 财政年份:2000
- 资助金额:
$ 1.54万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
A novel lectin-dependent activation pathway of complement
一种新的凝集素依赖性补体激活途径
- 批准号:
07044285 - 财政年份:1995
- 资助金额:
$ 1.54万 - 项目类别:
Grant-in-Aid for international Scientific Research
A NOVEL LECTIN-DEPENDENT ACTIVATION PATHWAY OF COMPLEMENT
一种新型的凝集素依赖性补体激活途径
- 批准号:
06454223 - 财政年份:1994
- 资助金额:
$ 1.54万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Production of chimeric protein to scavenge immune complexes
产生嵌合蛋白以清除免疫复合物
- 批准号:
02557026 - 财政年份:1990
- 资助金额:
$ 1.54万 - 项目类别:
Grant-in-Aid for Developmental Scientific Research (B)
相似国自然基金
基于MALDI-TOF MS结合电子倍增技术的血清外泌体完整蛋白UPAR和MASP2定量方法研究及其临床应用
- 批准号:82302641
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
内源性脂肪分泌肽MASP3抑制乳腺癌侵袭转移的应用基础研究
- 批准号:
- 批准年份:2021
- 资助金额:54.7 万元
- 项目类别:面上项目
VEGF通过磷酸化MASP1调节补体系统活化在HELLP综合征发病中的机制研究
- 批准号:82071668
- 批准年份:2020
- 资助金额:55 万元
- 项目类别:面上项目
MASP-2效应酶介导感染性肉芽肿形成、成熟的免疫调节机制研究
- 批准号:31370912
- 批准年份:2013
- 资助金额:15.0 万元
- 项目类别:面上项目
相似海外基金
胃癌と補体 ~抗補体薬は胃癌治療の次の一手になり得るか~
胃癌和补体 - 抗补体药物可能成为胃癌治疗的下一步吗?
- 批准号:
22K15972 - 财政年份:2022
- 资助金额:
$ 1.54万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
非アルコール性脂肪肝疾患の腸肝軸へ対する補体活性化因子MASP-3の機能解明
阐明补体激活剂 MASP-3 对非酒精性脂肪肝肠肝轴的功能
- 批准号:
22K16026 - 财政年份:2022
- 资助金额:
$ 1.54万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Molecular mechanism of tight junction maintenance by proteases
蛋白酶维持紧密连接的分子机制
- 批准号:
21K06156 - 财政年份:2021
- 资助金额:
$ 1.54万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Identification of the protease in blood that activates complement factor MASP-3
鉴定血液中激活补体因子 MASP-3 的蛋白酶
- 批准号:
21K07083 - 财政年份:2021
- 资助金额:
$ 1.54万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
補系経路活性化分子は、新たな中隔形成因子の一つとなりうるのか。
补体途径激活分子能否成为新的隔膜形成因子?
- 批准号:
19K09233 - 财政年份:2019
- 资助金额:
$ 1.54万 - 项目类别:
Grant-in-Aid for Scientific Research (C)